Alleviating effects of hydrogen on hyperhomocysteinemia and fatty liver induced by high-methionine diet

doi:10.12047/j.cjap.6382.2022.143

Abstract

Abstract: Objective: To investigate the alleviating effect of hydrogen (H₂) on homocysteine (Hcy) levels and non alcoholic fatty liver in rats with hyperhomocysteinemia (HHcy). Methods: After one week of adaptive feeding, Wistar rats were randomly divided into three groups: the general diet group (CHOW), the high methionine group (HMD), and the high methionine plus hydrogen rich water group (HMD+HRW), with 8 rats in each group. The CHOW group was fed with AIN-93G feed, while the HMD and HMD+HRW groups were fed with AIN-93G+2% methionine feed to construct an HHcy model. The HMD+HRW group was also gavaged with hydrogen rich water (3 ml/animal, twice a day, with a hydrogen concentration of 0.8 mmol/L), and body weight data were recorded. After 6 weeks of feeding, the plasma and liver samples were processed and collected. The plasma homocysteine (Hcy) and lipid contents of each group were measured, and the histological morphology of the liver was observed. The activities of key enzymes in the Hcy metabolism pathway and mRNA expression were detected in the liver. Results: Compared with the CHOW group rats, the Hcy level in the blood of HMD rats was significantly increased significantly (P＜0.05). Pathological tissue sections showed liver enlargement, injury, and fatty liver in the rats; Compared with the HMD group rats, the HMD+HRW group rats showed a significant decrease in Hcy in the blood, reduced liver damage, and increased Hcy metabolism key enzyme activity and mRNA expression in the liver, with statistical differences (P＜0.05). Conclusion: Hydrogen has a significant improvement effect on liver injury induced by HMD diet in HHcy rats, possibly by enhancing the three metabolic pathways of Hcy to reduce excessive Hcy in the body, thereby improving liver metabolic function and symptoms of non-alcoholic fatty liver disease.

Key words: hyperhomocysteinemia (HHcy), metabolic enzymes, non-alcoholic fatty liver disease (NAFLD), hydrogen rich water(HRW), folic acid, rats

CLC Number:

R333.4

CHU Wen-bin, DING Tian-qi, WEN Bo, LU Jun-yu, FAN Rong, CHEN Xue-wei. Alleviating effects of hydrogen on hyperhomocysteinemia and fatty liver induced by high-methionine diet[J]. CJAP, 2022, 38(6): 787-792.

References

[1] 李倩, 李东霞. 高血压合并高同型半胱氨酸血症的研究进展[J]. 心血管病学进展, 2018, 39(2): 187-190.
[2] Yao L, Wang C, Zhang X, et al.Hyperhomocysteinemia activates the aryl hydrocarbon receptor/CD36 pathway to promote hepatic steatosis in mice [J]. Hepatology, 2016, 64(1): 92-105.
[3] Balint B, Jepchumba VK, Guéant JL, et al. Mechanisms of homocysteine-induced damage to the endothelial, medial and adventitial layers of the arterial wall [J]. Biochimie, 2020, 173: 100-106.
[4] Jamison RL, Hartigan P, Kaufman JS, et al. Veterans affairs site investigators. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial [J]. JAMA, 2007, 298(10): 1163-1170.
[5] Ohsawa I, Ishikawa M, Takahashi K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals [J]. Nat Med, 2007, 13(6): 688-694.
[6] Ohta S. Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine [J]. Pharmacol Ther, 2014, 144(1): 1-11.
[7] Sun H, Chen L, Zhou W, et al. The protective role of hydrogen-rich saline in experimental liver injury in mice [J]. J Hepatol, 2011, 54(3): 471-480.
[8] Ohsawa I, Ishikawa M, Takahashi K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals [J]. Nat Med, 2007, 13(6): 688-694.
[9] Cai WW, Zhang MH, Yu YS, et al. Treatment with hydrogen molecule alleviates TNF-α-induced cell injury in osteoblast [J]. Mol Cell Biochem, 2013, 373(1-2): 1-9.
[10] Park DJ, Agarwal A, George JF. Heme oxygenase-1 expression in murine dendritic cell subpopulations: effect on CD8+ dendritic cell differentiation in vivo[J]. Am J Pathol, 2010, 176(6): 2831-2839.
[11] Li Q, Yu P, Zeng Q, et al. Neuroprotective effect of hydrogen-rich saline in global cerebral ischemia/reperfusion rats: Up-regulated tregs and down-regulated miR-21, miR-210 and NF-κB expression [J]. Neurochem Res, 2016, 41(10): 2655-2665.
[12] Cui J, Chen X, Zhai X, et al. Inhalation of water electrolysis-derived hydrogen ameliorates cerebral ischemia-reperfusion injury in rats - A possible new hydrogen resource for clinical use [J]. Neuroscience, 2016, 335: 232-241.
[13] Huang G, Zhou J, Zhan W, et al. The neuroprotective effects of intraperitoneal injection of hydrogen in rabbits with cardiac arrest [J]. Resuscitation, 2013, 84(5): 690-695.
[14] Tang X, Fu X, Liu Y, et al. Blockade of glutathione metabolism in IDH1-mutated glioma [J]. Mol Cancer Ther, 2020, 19(1): 221-230.
[15] 扈红蕾, 高健, 郭文君, 等. 富氢水在黄曲霉毒素B1致大鼠肝损伤模型中的抗损伤作用[J]. 生理学报, 2019, 71(5): 725-731.
[16] Zaric BL, Obradovic M, Bajic V, et al. Homocysteine and hyperhomocysteinaemia [J]. Curr Med Chem, 2019, 26(16): 2948-2961.
[17] Skovierová H, Vidomanová E, Mahmood S, et al. The molecular and cellular effect of homocysteine metabolism imbalance on human health[J]. Int J Mol Sci, 2016, 17(10): 1710-1733.
[18] 杜冰会. 口服叶酸干预高同型半胱氨酸血症疗效的预测模型的建立和评价[D]. 郑州大学, 2019.
[19] Shi JH, Lu JY, Chen HY, et al. Liver chrebp protects against fructose-induced glycogenic hepatotoxicity by regulating L-type pyruvate kinase [J]. Diabetes, 2020, 69(4): 591-602.
[20] Liang C, Zhang X, Yang M, et al. Recent progress in ferroptosis inducers for cancer therapy[J]. Adv Mater, 2019, 31(51): e1904197(1-25).